Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen vs DHEA in Perimenopausal and Menopausal Women
NCT07574216Recruiting
- Sponsor
- University of Arizona
- Start
- Aug 2026
- Primary completion
- Dec 2031
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised trial of dehydroepiandrosterone and estradiol vaginal cream in genitourinary syndrome of menopause (GSM) (2 arms), sponsored by University of Arizona. Primary endpoint: Genitourinary Symptoms at 6 months. Started Aug 2026; status: recruiting.
02
Drugs
dehydroepiandrosteroneestradiol vaginal cream
03
Conditions
genitourinary syndrome of menopause (GSM)
Beyond the preview
Go deeper on NCT07574216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574216.